iPremom
Molecular diagnostics for early prediction of pregnancy complications
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
iPremom is a Valencia (Paterna), Spain molecular diagnostics company focused on predicting pregnancy complications from maternal blood. Its MaiRa platform analyses cell-free RNA signals to assess preeclampsia risk from as early as week 9 of pregnancy and is offered in Spain as a laboratory-developed test under clinician prescription. In September 2026 the company announced a 15 million euro seed round led by Amadeus Capital Partners, with Asabys Partners and APEX Ventures participating, to fund clinical validation and commercial/regulatory expansion.
- Website
- ipremom.com/en
- Stage
- seed
- Location
- Paterna, Valencia, Spain
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- MaiRa — Blood test assessing preeclampsia risk from week 9 of pregnancy · Service